Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eva María Martínez Cáceres"'
Autor:
Concepción Violán, Pere Torán-Monserrat, Bibiana Quirant, Noemi Lamonja-Vicente, Lucía A. Carrasco-Ribelles, Carla Chacón, Josep Maria Manresa-Dominguez, Francesc Ramos-Roure, Rosalia Dacosta-Aguayo, Cristina Palacios-Fernández, Albert Roso-Llorach, Aleix Pujol, Dan Ouchi, Mónica Monteagudo, Pilar Montero-Alia, Rosa Garcia-Sierra, Fernando Arméstar, Maria Doladé, Nuria Prat, Josep Maria Bonet, Bonaventura Clotet, Ignacio Blanco, Marc Boigues-Pons, Nemesio Moreno-Millán, Julia G. Prado, Eva María Martínez Cáceres, for the ProHEpiC-19 study
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Understanding the immune response to the SARS-CoV-2 virus is critical for efficient monitoring and control strategies. The ProHEpic-19 cohort provides a fine-grained description of the kinetics of antibodies after SARS-CoV-2 infec
Externí odkaz:
https://doaj.org/article/b74f614863c3434bbbf833c28b70881f
Autor:
Joan, Puñet-Ortiz, José Vicente, Hervás-García, Aina, Teniente-Serra, Antonio, Cano-Orgaz, Maria José, Mansilla, Bibiana, Quirant-Sánchez, Juan, Navarro-Barriuso, Marco A, Fernández-Sanmartín, Silvia, Presas-Rodríguez, Cristina, Ramo-Tello, Eva María, Martínez-Cáceres
Publikováno v:
Cytometry. Part B, Clinical cytometry. 94(2)
In natalizumab-treated relapsing-remitting MS (RRMS) patients, various extended interval dosing strategies are under evaluation to minimize severe treatment-associated side effects, mainly progressive multifocal leukoencephalopathy development. Up to
Autor:
Miguel Angel, Pacha-González, Benjamí, Oller-Sales, Evarist, Feliu, Fuensanta, Millá, Marisol, Xandri, José, Troya, Josep, Roca, Joaquim, Riba, Manel, Fraile, Eva María, Martínez-Cáceres, Nivardo, Rodríguez, María Jesús, Martínez, Ricardo, Pujol-Borrell, Jaume, Fernández-Llamazares
Publikováno v:
Medicina clinica. 128(5)
The splenic function of patients followed by the Department of General and Digestive Surgery in the Hospital Universitari Germans Trias i Pujol (HUGTiP) from 1985 to 2003 for different degrees of splenic trauma according to the classification of the
Autor:
Judith Derdelinckx, María José Mansilla, Maxime De Laere, Wai-Ping Lee, Juan Navarro-Barriuso, Inez Wens, Irene Nkansah, Jasmijn Daans, Hans De Reu, Aneta Jolanta Keliris, Johan Van Audekerke, Verdi Vanreusel, Zoë Pieters, Annemie Van der Linden, Marleen Verhoye, Geert Molenberghs, Niel Hens, Herman Goossens, Barbara Willekens, Patrick Cras, Peter Ponsaerts, Zwi N. Berneman, Eva María Martínez-Cáceres, Nathalie Cools
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-20 (2019)
Abstract Background Although effective in reducing relapse rate and delaying progression, current therapies for multiple sclerosis (MS) do not completely halt disease progression. T cell autoimmunity to myelin antigens is considered one of the main m
Externí odkaz:
https://doaj.org/article/2366a29bc50643d4a9477ae81546bc64